Interest of an Auriculotherapy Session in Smoking Cessation

Launched by HOPITAL FOCH · May 5, 2021

Keywords

ClinConnect Summary

Smoking is a major risk factor for morbidity and mortality. The French High Authority for Health recommends that "All health professionals must advise every smoker to stop smoking, regardless of the form of tobacco used, and offer advice and assistance to quit". The modalities of accompaniment towards quitting and support during the withdrawal period vary according to each smoker, his or her degree of motivation, the intensity of his or her dependence, and any previous attempts.

Nicotine substitutes are the first-line drug treatment, and can be part of a strategy to stop using nicotine rig...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Be of legal age
• • Have an active smoking habit
• • Wish to quit smoking and nicotine completely (VAS of motivation ≥ 7 on a scale of 0 to 10)
• • Have signed a consent form;
• • Be affiliated with a health insurance plan.
• Exclusion Criteria:
• • Contraindication to the use of auriculotherapy (lesion or infection of the auricle) by cryotherapy (skin healing disorder, risk of hypo or hyperpigmentation);
• • Treatment with Varenicline (Champix®, etc...) or Bupropion hydrochloride (Zyban®, etc...) in progress; treatment with nicotine substitutes (patches, gum, nicotine e-cigarette)
• • Treatment by auriculotherapy or acupuncture in this indication in the previous 12 months;
• • Previous treatment with cryo-auriculotherapy;
• • Having to start any new smoking cessation treatment that could interfere with the study: specific drug treatment (antidepressant, morphine, anticonvulsant) or complementary therapy (psychological or mind-body treatment);
• • Difficulty complying with the treatment, questionnaire or study protocol;
• • Being deprived of liberty or under guardianship.